Employees: 21 (2023.0)Legal category: SCA (commandite par actions)Size: PMECreation date: 2002-09-01 (23 years)Status: ActiveBusiness sector: Location et location-bail d'autres biens personnels et domestiquesLocation: GREASQUE (13850), Bouches-du-Rhone
R'SUD MEDICAL : revenue, balance sheet and financial ratios
R'SUD MEDICAL is a French company
founded 23 years ago,
specialized in the sector Location et location-bail d'autres biens personnels et domestiques.
Based in GREASQUE (13850),
this company of category PME
shows in 2022 a revenue of 9.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - R'SUD MEDICAL (SIREN 443621685)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
9 604 392 €
10 372 478 €
11 913 115 €
12 059 200 €
10 604 413 €
10 656 217 €
N/C
Net income
429 414 €
511 163 €
461 662 €
928 871 €
1 353 734 €
1 047 796 €
1 174 041 €
561 862 €
1 230 541 €
EBITDA
N/C
N/C
1 971 668 €
2 668 512 €
3 652 010 €
3 273 590 €
3 128 451 €
2 548 699 €
-7 171 042 €
Net margin
N/C
N/C
4.8%
9.0%
11.4%
8.7%
11.1%
5.3%
N/C
Revenue and income statement
In 2024, R'SUD MEDICAL generates positive net income of 429 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 1.2 M€ -> 429 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
429 414 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 80%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 38%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
79.853%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
37.974%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
10.479
58.249
7.636
11.615
16.1
44.386
75.396
66.12
79.853
Financial autonomy
54.325
38.943
63.363
60.876
60.12
48.1
37.406
41.469
37.974
Repayment capacity
0.089
0.476
0.102
0.167
0.229
0.764
1.526
None
None
Cash flow / Revenue
40728.046%
19.255%
25.08%
22.649%
25.31%
21.518%
17.769%
None%
None%
Sector positioning
Debt ratio
79.852024
2022
2023
2024
Q1: 0.0
Med: 9.81
Q3: 79.47
Average+7 pts over 3 years
In 2024, the debt ratio of R'SUD MEDICAL (79.85) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
37.97%2024
2022
2023
2024
Q1: 5.79%
Med: 33.76%
Q3: 60.35%
Good
In 2024, the financial autonomy of R'SUD MEDICAL (38.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
1.53 years2022
2022
Q1: 0.0 years
Med: 0.03 years
Q3: 1.43 years
Average
In 2022, the repayment capacity of R'SUD MEDICAL (1.53) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 142.92. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
142.921
Liquidity indicators evolution R'SUD MEDICAL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
94.641
81.791
90.715
100.901
123.856
139.641
147.021
149.203
142.921
Interest coverage
-0.174
0.504
0.354
0.324
0.232
0.54
2.731
None
None
Sector positioning
Liquidity ratio
142.922024
2022
2023
2024
Q1: 106.8
Med: 176.44
Q3: 303.96
Average
In 2024, the liquidity ratio of R'SUD MEDICAL (142.92) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
2.73x2022
2022
Q1: 0.0x
Med: 0.04x
Q3: 1.23x
Excellent
In 2022, the interest coverage of R'SUD MEDICAL (2.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution R'SUD MEDICAL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
1 193 709 €
481 971 €
1 185 661 €
1 382 279 €
2 453 610 €
3 511 558 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
0
Customer payment term (days)
0
44
39
39
61
89
128
0
0
Supplier payment term (days)
65
77
51
62
53
98
134
0
0
Positioning of R'SUD MEDICAL in its sector
Comparison with sector Location et location-bail d'autres biens personnels et domestiques
Valuation estimate
Based on 69 transactions of similar company sales
(all years),
the value of R'SUD MEDICAL is estimated at
1 725 981 €
(range 675 382€ - 5 251 836€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2024
69 tx
675k€1725k€5251k€
1 725 981 €Range: 675 382€ - 5 251 836€
NAF 5 all-time
Valuation method used
Net Income Multiple
429 414 €
×
4.0x
=1 725 981 €
Range: 675 382€ - 5 251 836€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Location et location-bail d'autres biens personnels et domestiques)
Compare R'SUD MEDICAL with other companies in the same sector:
Yes, R'SUD MEDICAL generated a net profit of 429 k€ in 2024.
Where is the headquarters of R'SUD MEDICAL ?
The headquarters of R'SUD MEDICAL is located in GREASQUE (13850), in the department Bouches-du-Rhone.
Where to find the tax return of R'SUD MEDICAL ?
The tax return of R'SUD MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does R'SUD MEDICAL operate?
R'SUD MEDICAL operates in the sector Location et location-bail d'autres biens personnels et domestiques (NAF code 77.29Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart